Partner

 

 

 

 
 
 
 
 
 

FIZ, Frankfurt Biotechnology Innovation Center GmbH, Frankfurt am Main,
is a research cluster that works closely with industries, consequently making worldwide business representation and cooperation possible. Through the acquisition of both young and established companies, FIZ encourages co-operations and the exchange of ideas, thereby easing the way for collaboration between academic and applied research from which the founding businesses of FIZ
also profit. The shareholders of FIZ are the State of Hesse, the City of Frankfurt am Main, and the Chamber of Commerce and Industry (CCI), Frankfurt am Main. FIZ is located in Science City Frank-
furt-Riedberg in close proximity to the Goethe-University, two Max-Planck-Institutes, as well as other research institutes.

 

IBM
IBM, with sales revenues totaling USD 103.6 billion in 2008, is one of the world's largest IT and Business To Business Solutions providers. It currently employs nearly 400,000 people and is active in over 170 countries.
IBM is one of the world's largest providers of information technology (hardware, software, and services). Its solutions portfolio ranges from supercomputers via software and services, including consulting services, to financing. In teams positioned around the world and in collaboration with around 100,000 business partners, IBM assists clients of the most varied sizes with projects, inclu-
ding cross-border projects.
more...

 

Center for Information Sciences and Databases (CISD)
The Center for Information Sciences and Databases (CISD) is part of the Department of Biosystems Science and Engineering (D-BSSE) at the ETH Zurich and participates in the Swiss national Systems Biology initiative SystemsX.ch. Its mission is to establish and ensure simple, reliable access to data
of high quality and consistency with sufficient context to enable and support knowledge generation in Systems Biology. As a focused group of interdisciplinary experts, CISD is to provide an effective scientific service bridging the gap between applied biology and information technologies enabling cross-disciplinary research.

 

JSI medical systems
SEQUENCE Pilot a safe and fast software tool for the analysis of your sequencing data in research and diagnostics
Established more than 10 years ago in the Black Forest area in Germany JSI medical systems expanded to the United States of America in 2008. The company today is ranked among the leading providers of software for sequencing data analysis. JSI medical systems is offering optimal software solutions covering a wide field of sequencing techniques, such as Capillary Sequencing, Affymetrix Chip Resequencing, Next Generation Sequencing, MLPA Analysis and HLA Sequenced Based Typing. All applications were developed in close collaboration with their customers, characterized by outstanding user-friendliness, efficiency and optimal integration in the work routine. Safe and fast analysis of all incoming sequencing data, including a patient related report, is guaranteed. Sequencing data of all established sequencing systems (Applied Biosystems™, Beckman Coulter, Megabase, Roche, Illumina® etc.) can be analyzed.
more...

 

The Praunheimer Werkstätten gGmbH (pw°),
runs several rehabilitaton facilites for mentally handicapped adults from Frankfurt am Main and its eastward-lying Main-Taunus region. Our goal is to integrate people with mental handicaps into society. Care and sheltered living, vocational training and occupational programs are meant to help the disadvantaged to lead a normal life as much as possible. pw° provides occupational programs for about 750 people in workshops located in the suburbs of Praunheim, Fechenheim and Höchst, as well as care in adjacent vocational rehabilitation facilities. Within our five facilities we can house 150 clients as well as organize the care for 90 outpatient clients all over Frankfurt am Main. Our three government-subsidized workshops in Frankfurt am Main form an effective alliance that offers a broad range of products and services. We are always striving to expand our line of products and services.